Blanchard Z - Search Results

1

Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line.

Rush CM, Blanchard Z, Polaski JT, Osborne KS, Osby K, Vahrenkamp JM, Yang CH, Lum DH, Hagan CR, Leslie KK, Pufall MA, Thiel KW, Gertz J. Rush CM, et al. Among authors: blanchard z. Sci Rep. 2022 Nov 17;12(1):19731. doi: 10.1038/s41598-022-24211-8. Sci Rep. 2022. PMID: 36396974 Free PMC article.

2

Geminin overexpression induces mammary tumors via suppressing cytokinesis.

Blanchard Z, Malik R, Mullins N, Maric C, Luk H, Horio D, Hernandez B, Killeen J, Elshamy WM. Blanchard Z, et al. Oncotarget. 2011 Dec;2(12):1011-27. doi: 10.18632/oncotarget.363. Oncotarget. 2011. PMID: 22184288 Free PMC article.

3

Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.

Rodriguez AC, Blanchard Z, Maurer KA, Gertz J. Rodriguez AC, et al. Among authors: blanchard z. Horm Cancer. 2019 Jun;10(2-3):51-63. doi: 10.1007/s12672-019-0358-9. Epub 2019 Feb 2. Horm Cancer. 2019. PMID: 30712080 Free PMC article. Review.

4

Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer.

Blanchard Z, Vahrenkamp JM, Berrett KC, Arnesen S, Gertz J. Blanchard Z, et al. Genome Res. 2019 Sep;29(9):1429-1441. doi: 10.1101/gr.244780.118. Epub 2019 Jul 30. Genome Res. 2019. PMID: 31362937 Free PMC article.

5

Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.

Arnesen S, Blanchard Z, Williams MM, Berrett KC, Li Z, Oesterreich S, Richer JK, Gertz J. Arnesen S, et al. Among authors: blanchard z. Cancer Res. 2021 Feb 1;81(3):539-551. doi: 10.1158/0008-5472.CAN-20-1171. Epub 2020 Nov 12. Cancer Res. 2021. PMID: 33184109 Free PMC article.

6

Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs.

Arnesen S, Polaski JT, Blanchard Z, Osborne KS, Welm AL, O'Connell RM, Gertz J. Arnesen S, et al. Among authors: blanchard z. NAR Cancer. 2023 Jun 1;5(2):zcad027. doi: 10.1093/narcan/zcad027. eCollection 2023 Jun. NAR Cancer. 2023. PMID: 37275275 Free PMC article.

7

Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer.

Blanchard Z, Rush CM, Arnesen S, Vahrenkamp JM, Rodriguez AC, Jarboe EA, Brown C, Chang MEK, Flory MR, Mohammed H, Modzelewska K, Lum DH, Gertz J. Blanchard Z, et al. Mol Cancer Res. 2023 Oct 2;21(10):1023-1036. doi: 10.1158/1541-7786.MCR-22-0848. Mol Cancer Res. 2023. PMID: 37363949

8

BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.

Paul BT, Blanchard Z, Ridgway M, ElShamy WM. Paul BT, et al. Among authors: blanchard z. Oncogene. 2015 Jun 4;34(23):3036-52. doi: 10.1038/onc.2014.237. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132263

9

BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells.

Shimizu Y, Mullins N, Blanchard Z, Elshamy WM. Shimizu Y, et al. Among authors: blanchard z. Oncotarget. 2012 Mar;3(3):299-313. doi: 10.18632/oncotarget.462. Oncotarget. 2012. PMID: 22431556 Free PMC article.

10

Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Blanchard Z, Mullins N, Ellipeddi P, Lage JM, McKinney S, El-Etriby R, Zhang X, Isokpehi R, Hernandez B, Elshamy WM. Blanchard Z, et al. PLoS One. 2014 Apr 30;9(4):e95663. doi: 10.1371/journal.pone.0095663. eCollection 2014. PLoS One. 2014. PMID: 24789045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters